Preface |
|
xi | |
|
|
|
|
Body Composition Monitoring in Peritoneal Dialysis |
|
|
|
Application of Body Composition Monitoring to Peritoneal Dialysis Patients |
|
|
|
|
|
|
|
|
|
1 | (6) |
|
Fundamentals of Peritoneal Dialysis |
|
|
|
Peritoneal Ultrafiltration: Physiology and Failure |
|
|
7 | (8) |
|
|
Long-Term Changes in Solute and Water Transport |
|
|
15 | (7) |
|
|
|
|
|
|
Fluid Transport with Time on Peritoneal Dialysis: The Contribution of Free Water Transport and Solute Coupled Water Transport |
|
|
22 | (5) |
|
|
|
|
|
Biology of Peritoneal Membrane |
|
|
|
Peritoneal Dialysis: A Biological Membrane with a Nonbiological Fluid |
|
|
27 | (18) |
|
|
|
Mechanisms of Cell Death during Peritoneal Dialysis |
|
|
|
A Role for Osmotic and Oxidative Stress Gotloib, L. |
|
|
35 | (10) |
|
Different Aspects of Peritoneal Damage: Fibrosis and Sclerosis |
|
|
45 | (9) |
|
|
Biological Markers in the Peritoneal Dialysate Effluent: Are They Useful |
|
|
54 | (6) |
|
|
|
|
|
|
|
Peritoneal Dialysis Solutions |
|
|
|
Peritoneal Angiogenesis in Response to Dialysis Fluid |
|
|
60 | (7) |
|
|
Tailoring Peritoneal Dialysis Fluid for Optimal Acid-Base Targets |
|
|
67 | (7) |
|
|
Preservation and Modulation of Peritoneal Function |
|
|
|
A Potential Role of Pyruvate and Betaine |
|
|
74 | (8) |
|
|
How to Assess Peritoneal Transport: Which Test Should We Use? |
|
|
82 | (8) |
|
|
Cardiovascular Aspects of Dialysis |
|
|
|
Dry Body Weight and Ultrafiltration Targets in Peritoneal Dialysis |
|
|
90 | (6) |
|
|
|
|
|
Acute Central Hemodynamic Effects of Peritoneal Dialysis |
|
|
96 | (6) |
|
|
|
|
|
Cardiovascular Complications in Peritoneal Dialysis Patients |
|
|
102 | (8) |
|
|
Brain Natriuretic Peptide in Peritoneal Dialysis Patients |
|
|
110 | (7) |
|
|
|
|
Inflammation and Nutrition |
|
|
|
Metabolic Impact of Peritoneal Dialysis |
|
|
117 | (7) |
|
|
|
Is Obesity Associated with a Survival Advantage in Patients Starting Peritoneal Dialysis? |
|
|
124 | (8) |
|
|
|
|
|
|
Systemic and Local Inflammation in Peritoneal Dialysis: Mechanisms, Biomarkers and Effects on Outcome |
|
|
132 | (8) |
|
|
|
|
|
|
Adequacy in Peritoneal Dialysis: Kt/V and Beyond |
|
|
|
How Should We Measure Peritoneal Dialysis Adequacy in the Clinic |
|
|
140 | (7) |
|
|
Adequacy of Peritoneal Dialysis: Beyond Small Solute Clearance |
|
|
147 | (8) |
|
|
|
|
Importance of Residual Renal Function and Peritoneal Dialysis in Anuric Patients |
|
|
155 | (6) |
|
|
|
Complications of Peritoneal Dialysis and Their Management |
|
|
|
Insights on Peritoneal Dialysis-Related Infections |
|
|
161 | (8) |
|
|
New Treatment Options and Protocols for Peritoneal Dialysis-Related Peritonitis |
|
|
169 | (8) |
|
|
|
Lipid Disorders, Statins and the Peritoneal Membrane |
|
|
177 | (6) |
|
|
Complications of the Peritoneal Access and Their Management |
|
|
183 | (15) |
|
|
|
|
Calcium Phosphorus, Vitamin D Receptor and Peritoneal Dialysis |
|
|
|
Phosphate Balance in Peritoneal Dialysis Patients: Role of Ultrafiltration |
|
|
198 | (8) |
|
|
|
|
The Physiology of Vitamin D Receptor Activation |
|
|
206 | (7) |
|
|
Importance of Vitamin D Receptor Activation in Clinical Practice |
|
|
213 | (6) |
|
|
|
|
|
|
|
|
|
New Acquisitions in Therapy of Secondary Hyperparathyroidism in Chronic Kidney Disease and Peritoneal Dialysis Patients: Role of Vitamin D Receptor Activators |
|
|
219 | (8) |
|
|
|
|
|
|
|
Peritoneal Dialysis as a First-Choice Treatment: Advantages and Barriers |
|
|
|
What Can We Learn from Registry Data on Peritoneal Dialysis Outcomes? |
|
|
227 | (10) |
|
|
|
How to Persuade Peritoneal Dialysis - Skeptical Hemodialysis Fans |
|
|
237 | (6) |
|
|
How to Make Peritoneal Dialysis Affordable in Developing Countries |
|
|
243 | (7) |
|
|
|
|
|
|
|
|
Peritoneal Dialysis and Renal Transplantation |
|
|
250 | (7) |
|
|
|
|
|
|
|
Peritoneal Dialysis in Special Settings |
|
|
|
Decision Making around Dialysis Options |
|
|
257 | (4) |
|
|
Unplanned Start on Assisted Peritoneal Dialysis |
|
|
261 | (3) |
|
|
Peritoneal Dialysis in the Elderly |
|
|
264 | (6) |
|
|
Peritoneal Dialysis in Developing Countries |
|
|
270 | (8) |
|
|
|
|
|
|
Peritoneal Dialysis for Acute Kidney Injury: Techniques and Dose |
|
|
278 | (7) |
|
|
|
|
|
Cost Benefits of Peritoneal Dialysis in Specific Groups of Patients |
|
|
285 | (7) |
|
|
The Present and Future of Peritoneal Dialysis |
|
|
|
Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: Are There Differences in Outcome? |
|
|
292 | (8) |
|
|
|
|
|
The Wearable Artificial Kidney: Is Peritoneal Dialysis the Solution? |
|
|
300 | (6) |
|
|
What Will Be the Role of Industry in the Future? |
|
|
306 | (5) |
|
|
Role of the International Society for Peritoneal Dialysis (ISPD) in the Future of Peritoneal Dialysis |
|
|
311 | (9) |
|
Author Index |
|
320 | (2) |
Subject Index |
|
322 | |